Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03365622 · ClinicalTrials.gov registry record · Phase 4
Efficacy of IV Acetaminophen Versus Oral Acetaminophen
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 214
- Enrollment target
NCT03365622 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 214 participants.
The verdict
NCT03365622, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 214 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center. The standard surgical and post-operative care, including post-operative pain management will not be altered.
Interventions
- DRUG Acetaminophen
- DRUG Placebos
- DRUG Placebo Oral Tablet
- DRUG acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2018-08-08 |
| Est. Completion | 2024-04-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03365622
The ClinicalTrials.gov registry entry for NCT03365622 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT03365622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03365622 about?
NCT03365622 is a clinical study titled "Efficacy of IV Acetaminophen Versus Oral Acetaminophen". The aim of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of...
What is the current status of trial NCT03365622?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 214 participants. The study started on 2018-08-08. Estimated completion is 2024-04-10.
What interventions are being tested in trial NCT03365622?
The interventions under investigation include: Acetaminophen (DRUG), Placebos (DRUG), Placebo Oral Tablet (DRUG), acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03365622?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.